138 results
Page 2 of 7
8-K
EX-1.1
57o swuwq0orr7
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
424B5
e8rbjqwgr
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
s4uwx5qfux8s6in0v
13 Sep 22
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.2
3rc r3comh
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
S-8
EX-23.2
xc0r8lvgzc9bc3jpxf0b
12 Aug 22
Registration of securities for employees
8:23am
424B3
yvcgmlj5t
11 Jul 22
Prospectus supplement
4:32pm
POS AM
EX-23.1
0yctl 9kpc
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
POS AM
relhenn 89x6
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
EX-4.7
ikq6q0m2x2rd9jgyyc5
1 Jul 22
Shelf registration
4:13pm
S-3
EX-5.1
skhge
1 Jul 22
Shelf registration
4:13pm
S-3
EX-1.2
pgdne4 q7idqy
1 Jul 22
Shelf registration
4:13pm
S-3
EX-23.1
hzq3dt9aygl qd
1 Jul 22
Shelf registration
4:13pm
S-3
hwtukkd4
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.6
z11 pisxodk
1 Jul 22
Shelf registration
4:13pm
8-K
lhlhmw8n8z xfbd5ooq
3 Jun 22
Submission of Matters to a Vote of Security Holders
1:21pm
DEF 14A
x7u7zksn h04
28 Apr 22
Definitive proxy
8:36am
424B3
pig7g2e44
31 Mar 22
Prospectus supplement
11:42am
POS AM
EX-23.1
o7lz5jga0e t6ypk
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
POS AM
vc3f9
25 Mar 22
Prospectus update (post-effective amendment)
8:41am